NCT06264206View on ClinicalTrials.gov

Effect of Immunomodulatory Treatment on IVF (in Vitro Fertilization) Outcomes in Patients With KIR AA Genotype

NACompletedINTERVENTIONAL
Enrollment

65

Participants

Timeline

Start Date

January 1, 2022

Primary Completion Date

December 31, 2022

Study Completion Date

December 31, 2023

Conditions
Immunomodulatory DrugsKiller-cell Immunoglobulin-like Receptors (KIRs)KIR Alleles (KIR AA)
Interventions
DIAGNOSTIC_TEST

Killer-cell immunoglobulin-like receptors (KIRs) testing

patients were tested for KIRs, and based on the divided in the 2 arms. Patient from ARM KIR AA received immunomuodulatorc treatment.

Trial Locations (1)

410103

Calla Ivf Center, Oradea

All Listed Sponsors
lead

Calla IVF Center

OTHER

NCT06264206 - Effect of Immunomodulatory Treatment on IVF (in Vitro Fertilization) Outcomes in Patients With KIR AA Genotype | Biotech Hunter | Biotech Hunter